(Q51687818)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564121%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

title

Multifactorial, site-specific recurrence model after radical cystectomy for urothelial carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564121%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564121%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Paul L Crispen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564121%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Mark S Shimko

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564121%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Sara A Farmer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564121%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Michael L Blute

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564121%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Igor Frank

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564121%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

language of work or name

English

0 references

publication date

1 July 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564121%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564121%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

116

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564121%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564121%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

3399-3407

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564121%20AND%20SRC:MED&resulttype=core&format=json

Patterns of initial transitional cell recurrence in patients after cystectomy

6 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25202

7 January 2021

Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25202

7 January 2021

Impact of multimodal treatment on survival in patients with metastatic urothelial cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25202

7 January 2021

Long-term results following thoracotomy for metastatic bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25202

7 January 2021

Surgery for metastatic urothelial carcinoma with curative intent: the German experience (AUO AB 30/05)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25202

7 January 2021

Post-chemotherapy surgery in patients with unresectable or regionally metastatic bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25202

7 January 2021

Is there a therapeutic role for post-chemotherapy retroperitoneal lymph node dissection in metastatic transitional cell carcinoma of the bladder?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25202

7 January 2021

Is there a role for surgery in the management of metastatic urothelial cancer? The M. D. Anderson experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25202

7 January 2021

A stage specific approach to tumor surveillance after radical cystectomy for transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25202

7 January 2021

Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25202

7 January 2021

Upper tract tumour after radical cystectomy for transitional cell carcinoma of the bladder: incidence and risk factors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25202

7 January 2021

Upper tract recurrences following radical cystectomy: an analysis of prognostic factors, recurrence pattern and stage at presentation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25202

7 January 2021

Development of upper tract carcinoma after cystectomy for bladder carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25202

7 January 2021

Oncological followup after radical cystectomy for bladder cancer-is there any benefit?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25202

7 January 2021

Guidelines on bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25202

7 January 2021

Presentation, location and overall survival of pelvic recurrence after radical cystectomy for transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25202

7 January 2021

Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25202

7 January 2021

Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25202

7 January 2021

Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25202

7 January 2021

Combination of gemcitabine and paclitaxel as second-line chemotherapy for advanced urothelial carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25202

7 January 2021

Advanced bladder cancer: status of first-line chemotherapy and the search for active agents in the second-line setting

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25202

7 January 2021

Studies of the mortality of atomic bomb survivors. Report 12, Part I. Cancer: 1950-1990.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25202

7 January 2021

Radiation dose and second cancer risk in patients treated for cancer of the cervix.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25202

7 January 2021

Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25202

7 January 2021

Risk of Second Malignant Neoplasms Among Long-term Survivors of Testicular Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25202

7 January 2021

First analysis of cancer incidence and occupational radiation exposure based on the National Dose Registry of Canada

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25202

7 January 2021

Cancer incidence in the US radiologic technologists health study, 1983-1998.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25202

7 January 2021

Body mass index, physical activity, and bladder cancer in a large prospective study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25202

7 January 2021

Prospective study of body mass index, height, physical activity and incidence of bladder cancer in US men and women

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25202

7 January 2021